Asia Pacific Corneal Transplant Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2024 –2031 |
 Market Size (Base Year) |
USD 71.26 Million |
 Market Size (Forecast Year) |
USD 123.59 Million |
 CAGR |
% |
| Major Markets Players |
亚太角膜移植市场，按手术类型（内皮角膜移植术、穿透性角膜移植术、前板层角膜移植术 (ALK)、角膜缘干细胞移植、人工角膜移植等）、类型（人角膜和合成角膜）、供体类型（自体移植和同种异体移植）、移植类型（部分厚度移植（板层）和全厚度移植（穿透））、手术类型（常规手术、激光辅助手术）、适应症（Fuch 内皮营养不良、传染性角膜炎、大疱性角膜病变、圆锥角膜、再移植手术、角膜瘢痕、角膜溃疡等）、性别（女性和男性）、年龄组（老年、成人和儿童）、最终用户（医院、眼科诊所、门诊手术中心、学术和研究机构和其他）- 行业趋势及 2031 年预测
亚太角膜移植市场分析及规模
亚太地区角膜植入物市场受到多种因素的推动，包括角膜疾病患病率不断上升、人口老龄化加剧、技术进步、对微创手术的需求不断增长、对角膜移植的认识不断提高、政府举措和资金投入、混合型和散光型晶状体的采用率不断提高、交联手术越来越受欢迎、角膜植入物适应症不断扩大以及促进创新的竞争环境。这些因素共同推动了对角膜植入物的需求，尤其是在发达国家，因为患者寻求有效治疗视力障碍和圆锥角膜、福克斯营养不良和人工晶状体大泡性角膜病变等疾病。
Data Bridge Market Research分析，亚太地区角膜移植市场规模预计将从2023年的7126万美元增至2031年的1.2359亿美元，在2024年至2031年的预测期内，复合年增长率为7.2%。
|
报告指标 |
细节 |
|
预测期 |
2024 至 2031 年 |
|
基准年 |
2023 |
|
历史岁月 |
2022（可定制 2016-2021） |
|
定量单位 |
收入（百万美元） |
|
涵盖的领域 |
手术类型（内皮角膜移植术、穿透性角膜移植术、前板层角膜移植术 (ALK)、角膜缘干细胞移植、人工角膜移植等）、类型（人角膜和合成角膜）、供体类型（自体移植和同种异体移植）、移植类型（部分厚度移植（板层）和全厚度移植（穿透））、手术类型（常规手术、激光辅助手术）、适应症（Fuch 内皮营养不良、感染性角膜炎、大疱性角膜病变、圆锥角膜、再移植手术、角膜瘢痕、角膜溃疡等）、性别（女性和男性）、年龄组（老年人、成年人和儿童）、最终用户（医院、眼科诊所、门诊手术中心、学术和研究机构等） |
|
覆盖国家 |
中国、印度、日本、澳大利亚、韩国、新加坡、菲律宾、马来西亚、印度尼西亚、泰国和亚太地区其他地区 |
|
涵盖的市场参与者 |
蔡司集团 (Carl Zeiss Meditec AG.)、爱尔康、CorneaGen、Ziemer Ophthalmic Systems AG、RUMEX International Co. 等。 |
市场定义
角膜移植市场是指专注于用健康供体组织替换受损或患病角膜的外科手术的医疗领域。角膜移植，也称为角膜移植术，用于恢复患有圆锥角膜、角膜瘢痕、感染或角膜内皮功能障碍等疾病的患者的视力。该市场涵盖各种类型的移植手术，包括穿透性角膜移植术（全层角膜移植）和内皮角膜移植术（部分层角膜移植），并受到手术技术进步、供体组织可用性和术后护理改善的支持。随着眼部疾病在全球范围内变得越来越普遍，以及技术创新提高了手术的成功率，角膜移植市场持续增长，满足了对视力恢复日益增长的需求。
亚太角膜移植市场动态：
本节旨在了解市场驱动因素、优势、机遇、限制和挑战。以下内容将详细讨论所有这些内容：
驱动程序
- 眼部疾病发病率不断上升
眼部疾病的发病率不断上升，是推动亚太地区角膜移植市场发展的重要因素，因为圆锥角膜、Fuchs 角膜内皮营养不良症以及因感染或创伤导致的角膜瘢痕等疾病正变得越来越普遍。这些疾病可能导致严重的视力障碍或失明，从而促使人们对角膜移植作为一种修复性治疗的需求不断增长。眼部疾病的增多通常与人口老龄化、糖尿病发病率上升以及接触环境污染物和紫外线辐射增加等因素有关，这些因素可能会损害角膜。此外，诊断技术的进步使人们能够更早地发现这些疾病，从而及时采取干预措施，包括角膜移植。此外，人们对角膜健康的认识不断提高，以及改进的手术技术（如 Descemet 膜内皮角膜移植术 (DMEK) 和 Descemet 剥离自动内皮角膜移植术 (DSAEK)）的出现，也促使人们越来越多地接受角膜移植。随着全球眼部疾病负担不断增加，对角膜移植等有效解决方案的需求预计将增加，从而推动市场增长。
例如，
- 2023 年 6 月，根据 NCBI 发表的文章，进行了一项研究，以调查德国大型队列中圆锥角膜的患病率并评估可能的相关因素。圆锥角膜似乎是一种罕见的角膜疾病，患病率此前估计为 1:2000。然而，在最近相对较小的研究中，发现患病率更高。据报道，美国公民的患病率为 1:6000，以色列青少年的患病率为 1:1000，沙特阿拉伯儿童的患病率为 1:20。较新的研究发现，新西兰高中生的患病率估计为 1:191。在澳大利亚年轻人中，患病率高达 1:84。德国人口中圆锥角膜治疗的患病率比文献中之前使用最新技术（即 Scheimpflug 成像）报道的患病率高出约十倍，这成为市场增长的驱动力。
老年人口不断增加
老年人口的增加是亚太地区角膜移植市场的主要驱动力，因为老年人更容易患上各种眼部疾病，这些疾病可能导致角膜损伤和需要移植。与年龄相关的眼部疾病，如福克斯内皮营养不良症、大泡性角膜病变和其他退行性角膜疾病，随着年龄的增长而变得更加普遍，大大增加了对角膜移植的需求。此外，老年人更容易出现白内障手术并发症或患上糖尿病等慢性疾病，这会进一步加剧角膜恶化。随着亚太地区人口老龄化，需要角膜移植的人数预计将增加，特别是在人口老龄化迅速的地区。随着人们对角膜移植的可用性和成功率的认识不断提高，以及手术技术的进步为老年患者提供更好的结果和更快的恢复时间，这一趋势进一步加剧。因此，老年人口的增长是推动亚太地区角膜移植市场扩张的主要因素，凸显了对与年龄相关的角膜疾病的可获得且有效的治疗方案的需求。
机会
- 医疗基础设施建设
医疗基础设施的改善为亚太地区角膜移植市场提供了重大机遇，扩大了移植服务的可及性。基础设施的改善促进了更多医院和专科诊所的建立，使更多人能够接受角膜移植。医疗资源匮乏或农村地区的设施改善确保了以前无法获得专业眼科护理的患者现在可以接受基本的移植服务。
现代化的医疗机构配备了先进的手术技术和诊断工具，这直接提高了角膜移植的成功率并最大限度地减少了并发症。这些先进系统内的专业中心提供有针对性的专业知识和资源，进一步提高了手术效果和患者护理。这些设施的容量增加还支持更多的移植手术，有效地满足了患者的需求并减少了等待时间。
例如，
- 2024 年 4 月，根据《医院基础设施的兴起和现代化更新》一文，美国拥有强大的医疗基础设施，包括 6,000 多所医院和数千家小型诊所，为患者提供超过一百万张病床。这些基础设施包括各种基本要素，例如先进的研究实验室、尖端技术和各种医疗设备。此外，联邦政府一直在为该国医疗基础设施的持续现代化提供资金
- 2023 年 8 月，据 JLL India 称，印度一直在欢迎更多投资和创新，以应对未来危及生命的疾病和流行病，这反过来又有助于该国医疗保健和生命科学部门的发展
克制/挑战
- 角膜移植手术费用高昂
角膜移植手术的高昂费用严重制约了亚太地区角膜移植市场的增长，限制了患者的可及性和可负担性，尤其是在中低收入国家。角膜移植手术，包括传统的穿透性角膜移植术 (PK) 和先进的技术，如 Descemet 膜内皮角膜移植术 (DMEK) 或 Descemet 剥离自动内皮角膜移植术 (DSAEK)，通常不仅需要大量手术费用，还需要术前评估、术后护理、药物和随访的相关费用。此外，无论是通过眼库还是商业渠道获取捐赠角膜的成本，都进一步加重了经济负担。在许多地区，特别是医疗基础设施有限的地区，这些成本因缺乏保险覆盖或报销政策不足而加剧，使得很大一部分人无法负担角膜移植的费用。此外，对专业手术专业知识和先进设备的需求增加了总体费用，从而限制了这些手术仅在城市地区设备齐全的医疗中心进行。因此，角膜移植手术的高成本阻碍了市场增长，减少了潜在的患者数量，特别是在医疗资源匮乏的地区，这些地区的角膜疾病负担往往最重，获得负担得起的医疗服务的机会有限。
例如，
- 根据 Indiaorgantransplant.com 发布的数据，印度眼部移植手术的平均费用约为 210,000 卢比（2,600 美元）至 260,000 卢比（3,200 美元）。费用取决于多种因素，例如手术类型、外科医生费用、医院费用和其他相关费用。此外，印度的移植平均费用远高于任何其他治疗，这成为人们选择不进行移植手术的主要因素，并制约了市场的增长
最新动态
- 2024 年 1 月，卡尔蔡司印度医疗技术部门在班加罗尔 Nethradhama Super Speciality 举办的 Phaco Festival 上展示了白内障和屈光手术工作流程。在 Phaco Festival 上，蔡司对白内障和角膜屈光手术工作流程的变革性影响备受关注
- 2024 年 6 月，CorneaGen 今天宣布推出角膜移植术用角膜组织添加 (CTAK)，这是一种创新且极为有效的圆锥角膜眼角膜轮廓解决方案。CTAK 由 CorneaGen 与 CTAK LLC 和 Ziemer 合作开发，可提供患者可用、经伽马射线照射的无菌、无免疫原性的角膜组织片段，这些片段经过激光切割并根据患者特定的圆锥严重程度和位置进行定制
- 2024 年 1 月，总部位于西雅图的 CorneaGen 很高兴地宣布，其眼部恢复服务将扩展到加利福尼亚州北部和南部。通过此次服务扩展，CorneaGen 现在将为全州的机构提供眼部恢复和捐献组织处理服务，从而为其加利福尼亚州合作机构的患者、家属和员工带来更好的体验
- 2024 年 8 月，蔡司延续其在全球屈光行业的势头，超过 1000 万只眼睛接受了蔡司 SMILE 和蔡司 SMILE pro 治疗；蔡司宣布在消费电子市场首次采用蔡司 SMILE pro 技术进行透镜提取治疗远视
亚太角膜移植市场范围
根据手术类型、类型、供体类型、移植类型、手术类型、适应症、性别、年龄组和最终用户，亚太角膜移植市场可分为八个显著的细分市场。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。
程序类型
- 内皮角膜移植术
- 穿透性角膜移植术
- 前板层角膜移植术 (ALK)
- 角膜缘干细胞移植
- 人工角膜移植
- 其他的
根据手术类型，市场分为内皮角膜移植术、穿透性角膜移植术、前板层角膜移植术 (ALK)、角膜缘干细胞移植、人工角膜移植等。
类型
- 人类角膜
- 合成的
根据类型，市场分为人类角膜和合成角膜。
供体类型
- 同种异体移植
- 自体移植
根据捐赠者类型，市场分为同种异体移植和自体移植。
移植物类型
- 部分厚度移植（层状）
- 全层移植（穿透性）
根据移植类型，市场分为部分厚度移植（板层）、全厚度移植（穿透）。
手术类型
- 传统手术
- 激光辅助手术
根据手术类型，市场分为传统手术和激光辅助手术。
指征
- 福克斯内皮营养不良症
- 传染性角膜炎
- 大泡性角膜病变
- 圆锥角膜
- 再移植程序
- 角膜瘢痕
- 角膜溃疡
- 其他的
根据适应症，市场分为福克斯角膜内皮营养不良症、传染性角膜炎、大泡性角膜病变、圆锥角膜、再移植手术、角膜瘢痕、角膜溃疡等。
性别
- 女性
- 男性
根据性别，市场分为女性和男性。
年龄组
- 老年
- 成人
- 儿科
根据年龄组，市场分为老年人、成年人和儿童。
最终用户
- 医院，
- 眼科诊所，
- 门诊手术中心，
- 学术及研究机构
- 其他的
根据最终用户，市场分为医院、眼科诊所、门诊手术中心、学术和研究机构等。
亚太角膜移植市场区域分析/见解
对亚太角膜移植市场进行分析，并根据上述手术类型、类型、捐赠者类型、移植类型、手术类型、适应症、性别、年龄组和最终用户提供市场规模洞察和趋势。
本市场报告涵盖的国家包括中国、印度、日本、澳大利亚、韩国、新加坡、菲律宾、马来西亚、印度尼西亚、泰国和亚太其他地区。
由于中国人口众多、医疗支出不断增加、制药行业不断扩张、消费者意识不断增强、治疗需求不断增加，以及医疗保健基础设施不断发展和患病率不断上升，中国有望在亚太市场占据主导地位。
报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和市场监管变化。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测各个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了区域品牌的存在和可用性以及它们因来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
竞争格局和亚太角膜移植市场份额分析
亚太角膜移植市场根据手术类型、捐赠者类型、移植类型、手术类型、适应症、性别、年龄组和最终用户分为八个显著的部分。
亚太角膜移植市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、区域存在、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对亚太角膜移植市场的关注有关。
亚太地区角膜移植市场的主要参与者包括蔡司集团 (Carl Zeiss Meditec AG.)、爱尔康、CorneaGen、Ziemer Ophthalmic Systems AG 和 RUMEX International Co. 等。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE ASIA-PACIFIC CORNEAL IMPLANTS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET END USER COVERAGE GRID
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTLE ANALYSIS
4.2 PORTERS FIVE FORCES ANALYSIS
5 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: REGULATIONS
5.1 REGULATORY AUTHORITIES IN THE ASIA-PACIFIC REGION
5.2 NORTH AMERICA REGULATORY SCENARIO
5.3 EUROPE REGULATORY SCENARIO
5.4 MIDDLE EAST AND AFRICA REGULATORY SCENARIO
5.5 SOUTH AMERICA REGULATORY SCENARIO
6 CUSTOMIZATION
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASING PREVALENCE OF EYE DISEASES
7.1.2 RISING GERIATRIC POPULATION
7.1.3 TECHNOLOGICAL ADVANCEMENTS IN CORNEAL IMPLANTS
7.1.4 RISE IN MINIMALLY INVASIVE SURGERY IN CORNEAL TRANSPLANT
7.2 RESTRAINTS
7.2.1 HIGH COST ASSOCIATED WITH CORNEAL TRANSPLANT SURGERY
7.2.2 SHORTAGE OF DONORS IN CORNEAL TRANSPLANT
7.3 OPPORTUNITIES
7.3.1 RISE IN HEALTHCARE INFRASTRUCTURE
7.3.2 INCREASE IN PUBLIC AWARENESS AND EDUCATION
7.3.3 PARTNERSHIPS AND COLLABORATIONS ASSOCIATED WITH CORNEAL TRANSPLANTS
7.4 CHALLENGES
7.4.1 SURGICAL AND POST-SURGICAL COMPLICATIONS
7.4.2 LIMITED AWARENESS AND TRAINING
8 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY TYPE
8.1 OVERVIEW
8.2 HUMAN CORNEA
8.3 SYNTHETIC
9 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE
9.1 OVERVIEW
9.2 ENDOTHELIAL KERATOPLASTY
9.2.1 DESCEMET'S MEMBRANE ENDOTHELIAL KERATOPLASTY (DMEK)
9.2.2 DESCEMET'S STRIPPING ENDOTHELIAL KERATOPLASTY(DSEK)/DESCEMET'S STRIPPING AUTOMATED ENDOTHELIAL KERATOPLASTY (DSAEK)
9.3 PENETRATING KERATOPLASTY
9.4 ANTERIOR LAMELLAR KERATOPLASTY (ALK)
9.4.1 DEEP ANTERIOR LAMELLAR KERATOPLASTY (DALK)
9.4.2 SUPERFICIAL ANTERIOR LAMELLAR KERATOPLASTY (SALK)
9.5 CORNEAL LIMBAL STEM CELL TRANSPLANT
9.6 ARTIFICIAL CORNEA TRANSPLANT
9.7 OTHERS
10 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY DONOR TYPE
10.1 OVERVIEW
10.2 ALLOGRAFT
10.3 AUTOGRAFT
11 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY INDICATION
11.1 OVERVIEW
11.2 FUCH'S ENDOTHELIAL DYSTROPHY
11.3 INFECTIOUS KERATITIS
11.4 BULLOUS KERATOPATHY
11.5 KERATOCONUS
11.6 REGRAFT PROCEDURES
11.7 CORNEAL SCARRING
11.8 CORNEAL ULCERS
11.9 OTHERS
12 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE
12.1 OVERVIEW
12.2 PARTIAL THICKNESS GRAFTS (LAMELLAR)
12.2.1 DEEP LAMELLAR GRAFTS
12.2.2 SUPERFICIAL LAMELLAR GRAFTS
12.3 FULL THICKNESS GRAFTS (PENETRATING)
13 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE
13.1 OVERVIEW
13.2 CONVENTIONAL SURGERY
13.3 LASER-ASSISTED SURGERY
14 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY GENDER
14.1 OVERVIEW
14.2 FEMALE
14.3 MALE
15 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY AGE GROUP
15.1 OVERVIEW
15.2 GERIATRIC
15.3 ADULT
15.4 PEDIATRIC
16 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY END USER
16.1 OVERVIEW
16.2 HOSPITALS
16.3 EYE CLINICS
16.4 AMBULATORY SURGICAL CENTERS
16.5 ACADEMIC & RESEARCH INSTITUTES
16.6 OTHERS
17 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY REGION
17.1 ASIA-PACIFIC
17.1.1 CHINA
17.1.2 INDIA
17.1.3 JAPAN
17.1.4 AUSTRALIA
17.1.5 SOUTH KOREA
17.1.6 SINGAPORE
17.1.7 PHILIPPINES
17.1.8 MALAYSIA
17.1.9 INDONESIA
17.1.10 THAILAND
17.1.11 REST OF ASIA-PACIFIC
18 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: COMPANY LANDSCAPE
18.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
19 SWOT ANALYSIS
20 COMPANY PROFILES
20.1 ZEISS GROUP (CARL ZEISS MEDITEC AG.)
20.1.1 COMPANY SNAPSHOT
20.1.2 REVENUE ANALYSIS
20.1.3 COMPANY SHARE ANALYSIS
20.1.4 PRODUCT PORTFOLIO
20.1.5 RECENT DEVELOPMENTS
20.2 ALCON
20.2.1 COMPANY SNAPSHOT
20.2.2 REVENUE ANALYSIS
20.2.3 COMPANY SHARE ANALYSIS
20.2.4 PRODUCT PORTFOLIO
20.2.5 RECENT DEVELOPMENT
20.3 CORNEAGEN
20.3.1 COMPANY SNAPSHOT
20.3.2 COMPANY SHARE ANALYSIS
20.3.3 PRODUCT PORTFOLIO
20.3.4 RECENT DEVELOPMENT
20.4 ZIEMER OPHTHALMIC SYSTEMS AG
20.4.1 COMPANY SNAPSHOT
20.4.2 COMPANY SHARE ANALYSIS
20.4.3 PRODUCT PORTFOLIO
20.4.4 RECENT DEVELOPMENT
20.5 RUMEX INTERNATIONAL CO.
20.5.1 COMPANY SNAPSHOT
20.5.2 COMPANY SHARE ANALYSIS
20.5.3 PRODUCT PORTFOLIO
20.5.4 RECENT DEVELOPMENT
20.6 AJL OPHTHALMIC S.A.
20.6.1 COMPANY SNAPSHOT
20.6.2 PRODUCT PORTFOLIO
20.6.3 RECENT DEVELOPMENT
20.7 CORNEAT VISION
20.7.1 COMPANY SNAPSHOT
20.7.2 PRODUCT PORTFOLIO
20.7.3 RECENT DEVELOPMENT
20.8 FLORIDA LIONS EYE BANK
20.8.1 COMPANY SNAPSHOT
20.8.2 PRODUCT PORTFOLIO
20.8.3 RECENT DEVELOPMENT
20.9 KERAMED, INC.
20.9.1 COMPANY SNAPSHOT
20.9.2 PRODUCT PORTFOLIO
20.9.3 RECENT DEVELOPMENT
20.1 MASSACHUSETTS EYE AND EAR
20.10.1 COMPANY SNAPSHOT
20.10.2 PRODUCT PORTFOLIO
20.10.3 RECENT DEVELOPMENT
20.11 OCL VISION
20.11.1 COMPANY SNAPSHOT
20.11.2 SERVICE PORTFOLIO
20.11.3 RECENT DEVELOPMENT
20.12 OVATION INTERNATIONAL
20.12.1 COMPANY SNAPSHOT
20.12.2 PRODUCT PORTFOLIO
20.12.3 RECENT DEVELOPMENT
20.13 SAN DIEGO EYE BANK
20.13.1 COMPANY SNAPSHOT
20.13.2 SERVICE PORTFOLIO
20.13.3 RECENT DEVELOPMENT
21 QUESTIONNAIRE
22 RELATED REPORTS
表格列表
TABLE 1 NUMBER OF CORNEAL TRANSPLANTS IN EACH COUNTRY, BY SURGERY TYPE
TABLE 2 NUMBER OF CORNEAL TRANSPLANTS IN EACH COUNTRY, BY INDICATION
TABLE 3 NUMBER OF CORNEAL TRANSPLANTS IN EACH COUNTRY, BY AGE
TABLE 4 NUMBER OF PATIENTS WAITING IN EACH COUNTRY
TABLE 5 NUMBER OF CORNEAL TRANSPLANTS IN EACH COUNTRY, BY DONOR TYPE
TABLE 6 PERCENTAGE OF HOSPITALS IN EACH COUNTRY WHERE CORNEAL TRANSPLANTS ARE PERFORMED (CLINICS OR HOSPITALS).
TABLE 7 AVERAGE COST FOR THE CORNEAL TRANSPLANT (PER/EYE) WITH RESPECT TO THE PROCEDURE TYPE IN ASIA-PACIFIC (INDIA)
TABLE 8 AVERAGE COST FOR THE CORNEAL TRANSPLANT WITH RESPECT TO THE PROCEDURE TYPE IN EUROPE
TABLE 9 AVERAGE COST FOR THE CORNEAL TRANSPLANT WITH RESPECT TO THE PROCEDURE TYPE IN SOUTH AMERICA
TABLE 10 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 11 ASIA-PACIFIC HUMAN CORNEA IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 12 ASIA-PACIFIC SYNTHETIC IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 13 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 14 ASIA-PACIFIC ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 15 ASIA-PACIFIC ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 16 ASIA-PACIFIC PENETRATING KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 17 ASIA-PACIFIC ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 18 ASIA-PACIFIC ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 19 ASIA-PACIFIC CORNEAL LIMBAL STEM CELL TRANSPLANT IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 20 ASIA-PACIFIC ARTIFICIAL CORNEA TRANSPLANT IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 21 ASIA-PACIFIC OTHERS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 22 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 23 ASIA-PACIFIC ALLOGRAFT IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 24 ASIA-PACIFIC ALLOGRAFT IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 25 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 26 ASIA-PACIFIC FUCH'S ENDOTHELIAL DYSTROPHY IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 27 ASIA-PACIFIC INFECTIOUS KERATITIS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 28 ASIA-PACIFIC BULLOUS KERATOPATHY IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 29 ASIA-PACIFIC KERATOCONUS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 30 ASIA-PACIFIC REGRAFT PROCEDURES IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 31 ASIA-PACIFIC CORNEAL SCARRING IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 32 ASIA-PACIFIC CORNEAL ULCERS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 33 ASIA-PACIFIC OTHERS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 34 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 35 ASIA-PACIFIC PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 36 ASIA-PACIFIC PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 37 ASIA-PACIFIC FULL THICKNESS GRAFTS (PENETRATING) IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 38 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 39 ASIA-PACIFIC CONVENTIONAL SURGERY IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 40 ASIA-PACIFIC LASER-ASSISTED SURGERY IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 41 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 42 ASIA-PACIFIC FEMALE IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 43 ASIA-PACIFIC MALE IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 44 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 45 ASIA-PACIFIC GERIATRIC IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 46 ASIA-PACIFIC ADULT IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 47 ASIA-PACIFIC PEDIATRIC IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 48 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 49 ASIA-PACIFIC HOSPITALS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 50 ASIA-PACIFIC EYE CLINICS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 51 ASIA-PACIFIC AMBULATORY SURGICAL CENTERS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 52 ASIA-PACIFIC ACADEMIC & RESEARCH INSTITUTES IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 53 ASIA-PACIFIC OTHERS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 54 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)
TABLE 55 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 56 ASIA-PACIFIC ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 57 ASIA-PACIFIC ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 58 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 59 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 60 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 61 ASIA-PACIFIC PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 62 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 63 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 64 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 65 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 66 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 67 CHINA CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 68 CHINA ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 69 CHINA ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 70 CHINA CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 71 CHINA CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 72 CHINA CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 73 CHINA PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 74 CHINA CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 75 CHINA CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 76 CHINA CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 77 CHINA CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 78 CHINA CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 79 INDIA CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 80 INDIA ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 81 INDIA ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 82 INDIA CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 83 INDIA CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 84 INDIA CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 85 INDIA PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 86 INDIA CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 87 INDIA CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 88 INDIA CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 89 INDIA CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 90 INDIA CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 91 JAPAN CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 92 JAPAN ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 93 JAPAN ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 94 JAPAN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 95 JAPAN CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 96 JAPAN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 97 JAPAN PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 98 JAPAN CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 99 JAPAN CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 100 JAPAN CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 101 JAPAN CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 102 JAPAN CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 103 AUSTRALIA CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 104 AUSTRALIA ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 105 AUSTRALIA ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 106 AUSTRALIA CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 107 AUSTRALIA CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 108 AUSTRALIA CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 109 AUSTRALIA PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 110 AUSTRALIA CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 111 AUSTRALIA CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 112 AUSTRALIA CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 113 AUSTRALIA CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 114 AUSTRALIA CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 115 SOUTH KOREA CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 116 SOUTH KOREA ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 117 SOUTH KOREA ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 118 SOUTH KOREA CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 119 SOUTH KOREA CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 120 SOUTH KOREA CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 121 SOUTH KOREA PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 122 SOUTH KOREA CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 123 SOUTH KOREA CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 124 SOUTH KOREA CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 125 SOUTH KOREA CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 126 SOUTH KOREA CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 127 SINGAPORE CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 128 SINGAPORE ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 129 SINGAPORE ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 130 SINGAPORE CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 131 SINGAPORE CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 132 SINGAPORE CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 133 SINGAPORE PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 134 SINGAPORE CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 135 SINGAPORE CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 136 SINGAPORE CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 137 SINGAPORE CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 138 SINGAPORE CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 139 PHILIPPINES CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 140 PHILIPPINES ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 141 PHILIPPINES ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 142 PHILIPPINES CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 143 PHILIPPINES CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 144 PHILIPPINES CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 145 PHILIPPINES PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 146 PHILIPPINES CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 147 PHILIPPINES CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 148 PHILIPPINES CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 149 PHILIPPINES CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 150 PHILIPPINES CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 151 MALAYSIA CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 152 MALAYSIA ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 153 MALAYSIA ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 154 MALAYSIA CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 155 MALAYSIA CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 156 MALAYSIA CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 157 MALAYSIA PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 158 MALAYSIA CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 159 MALAYSIA CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 160 MALAYSIA CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 161 MALAYSIA CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 162 MALAYSIA CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 163 INDONESIA CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 164 INDONESIA ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 165 INDONESIA ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 166 INDONESIA CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 167 INDONESIA CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 168 INDONESIA CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 169 INDONESIA PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 170 INDONESIA CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 171 INDONESIA CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 172 INDONESIA CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 173 INDONESIA CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 174 INDONESIA CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 175 THAILAND CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 176 THAILAND ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 177 THAILAND ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 178 THAILAND CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 179 THAILAND CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 180 THAILAND CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 181 THAILAND PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 182 THAILAND CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 183 THAILAND CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 184 THAILAND CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 185 THAILAND CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 186 THAILAND CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 187 REST OF ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
图片列表
FIGURE 1 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: SEGMENTATION
FIGURE 2 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: DATA TRIANGULATION
FIGURE 3 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: DROC ANALYSIS
FIGURE 4 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: MARKET END USER COVERAGE GRID
FIGURE 8 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: DBMR MARKET POSITION GRID
FIGURE 9 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: SEGMENTATION
FIGURE 11 SIX SEGMENTS COMPRISE THE ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE
FIGURE 12 EXECUTIVE SUMMARY
FIGURE 13 STRATEGIC DECISIONS
FIGURE 14 INCREASING PREVALENCE OF EYE DISEASES IS DRIVING THE GROWTH OF THE ASIA-PACIFIC CORNEAL TRANSPLANT MARKET FROM 2024 TO 2031
FIGURE 15 THE ENDOTHELIAL KERATOPLASTY SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC CORNEAL TRANSPLANT MARKET IN 2024 AND 2031
FIGURE 16 DROC ANALYSIS
FIGURE 17 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: BY TYPE, 2023
FIGURE 18 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: BY TYPE, 2024-2031 (USD THOUSAND)
FIGURE 19 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: TYPE, CAGR (2024-2031)
FIGURE 20 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: TYPE, LIFELINE CURVE
FIGURE 21 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: BY PROCEDURE TYPE, 2023
FIGURE 22 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: BY PROCEDURE TYPE, 2024-2031 (USD THOUSAND)
FIGURE 23 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: PROCEDURE TYPE, CAGR (2024-2031)
FIGURE 24 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: PROCEDURE TYPE, LIFELINE CURVE
FIGURE 25 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: BY DONOR TYPE, 2023
FIGURE 26 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: BY DONOR TYPE, 2024-2031 (USD THOUSAND)
FIGURE 27 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: DONOR TYPE, CAGR (2024-2031)
FIGURE 28 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: DONOR TYPE, LIFELINE CURVE
FIGURE 29 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: BY INDICATION, 2023
FIGURE 30 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: BY INDICATION, 2024-2031 (USD THOUSAND)
FIGURE 31 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: BY INDICATION, CAGR (2024-2031)
FIGURE 32 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: BY INDICATION, LIFELINE CURVE
FIGURE 33 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: BY GRAFT TYPE, 2023
FIGURE 34 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: BY GRAFT TYPE, 2024-2031 (USD THOUSAND)
FIGURE 35 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: BY GRAFT TYPE, CAGR (2024-2031)
FIGURE 36 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: BY GRAFT TYPE, LIFELINE CURVE
FIGURE 37 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: BY SURGERY TYPE, 2023
FIGURE 38 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: BY SURGERY TYPE, 2024-2031 (USD THOUSAND)
FIGURE 39 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: BY SURGERY TYPE, CAGR (2024-2031)
FIGURE 40 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: BY SURGERY TYPE, LIFELINE CURVE
FIGURE 41 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: BY GENDER, 2023
FIGURE 42 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: BY GENDER, 2024-2031 (USD THOUSAND)
FIGURE 43 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: BY GENDER, CAGR (2024-2031)
FIGURE 44 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: BY GENDER, LIFELINE CURVE
FIGURE 45 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: BY AGE GROUP, 2023
FIGURE 46 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: BY AGE GROUP, 2024-2031 (USD THOUSAND)
FIGURE 47 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: BY AGE GROUP, CAGR (2024-2031)
FIGURE 48 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: BY AGE GROUP, LIFELINE CURVE
FIGURE 49 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: BY END USER, 2023
FIGURE 50 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: BY END USER, 2024-2031 (USD THOUSAND)
FIGURE 51 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: BY END USER, CAGR (2024-2031)
FIGURE 52 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: BY END USER, LIFELINE CURVE
FIGURE 53 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: SNAPSHOT (2023)
FIGURE 54 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: COMPANY SHARE 2023 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
